脑部放疗，上午比下午敏感许多！
7 Y# r, I" d3 U' [" m' _( p" ?2 L: [/ l* X! F! E' s
1 |9 V# [ j5 ^; W9 `4 W) U
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
) n+ h& ?8 z( r. E& ?/ EGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?7 R* K& A9 u& O$ z1 v# ?6 ^; P9 k
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
- k* O' V2 C# P4 p4 ^/ w0 y; |3 VSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.0 O4 I# ]3 f2 a6 x2 t. |- f
( }8 t* x$ c# F: h k* I. ?Abstract
/ y+ ^: d' s6 ?* ]BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
( z' F, G! A, U* R" k" w
. W9 A2 ]. c W* _METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
' w& W& Z: z, l) [/ E! N1 p4 E# q7 K# y& Y8 Y4 h0 G
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
; C% x) @4 W- o! C+ T
5 w. B; J n5 ?/ U1 Z. G/ _5 cCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, u5 d2 q. g: b- ^# ^) Y" a( T% n' t/ G5 h2 q
|
: ]4 U+ V3 Z% J% `3 E9 b! D
显身卡
